Calculating concentration and injection volume correctly seems trivial, but it is the most common source of error
The trial status is listed as "Unknown" it was reportedly cancelled in 2016, and no results were ever published
BPC-157 Side Effects & Safety Reported side effects fall into three buckets: directly observed effects in pilot studies, theoretical risks based on mechanism, and route-specific issues
Cagrilintide + Retatrutide Storage & Handling Storage Reference (Both Compounds) State Lyophilized (long-term) Cagrilintide -4 F (-20 C), 12+ months Retatrutide -4 F (-20 C), 12+ months State Lyophilized (short-term) Cagrilintide 35.6-46.4 F (2-8 C), several months Retatrutide 35.6-46.4 F (2-8 C), several months State Reconstituted (liquid) Cagrilintide 35.6-46.4 F (2-8 C), 28-30 days Retatrutide 35.6-46.4 F (2-8 C), 28-30 days State Color when reconstituted Cagrilintide Clear, colorless Retatrutide Clear, colorless State Shake